A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.

British journal of cancer

Volumn 111, Issue 6, 2014, Pages 1072-1079

  Cheah, C Y ^a   Herbert, K E ^a   O'Rourke, K ^a   Kennedy, G A ^a   George, A ^a   Fedele, P L ^a   Gilbertson, M ^a   Tan, S Y ^a   Ritchie, D S ^a   Opat, S S ^a   Prince, H M ^a   Dickinson, M ^a   Burbury, K ^a   Wolf, M ^a   Januszewicz, E H ^a   Tam, C S ^a   Westerman, D A ^a   Carney, D A ^a   Harrison, S J ^a   Seymour, J F ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; R CHOP PROTOCOL; R-CHOP PROTOCOL; RITUXIMAB; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; LARGE CELL LYMPHOMA; MALE; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INJECTIONS, SPINAL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; VINCRISTINE; YOUNG ADULT;

EID: 84908481527     PISSN: None     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.405     Document Type: Article

References (0)